Replies to post #81 on Nuvo Research Inc (MRVFF)

[CommonCents4Dollars]

My thoughts, BUY, WF10 top line results are to be released mid-February.

Nuvo Research currently sitting on $5 CASH per share, no debt, revenue generating drugs plus potential blockbuster drug WF10.

Again, my thoughts, BUY, this stock is on sale based on the big picture.